Celanese Corporation announced on February 10, 2026 that it will raise the prices of its key acetyl‑chain products in the Western Hemisphere. The company will increase the price of acetic acid by $50 per metric ton, vinyl acetate monomer (VAM) by $100, acetic anhydride by $60, and esters by $50, all effective immediately or as existing contracts allow.
The Acetyl Chain segment, which has historically delivered stable cash flow, posted net sales of $1.1 billion in the fourth quarter of 2024—down 7% sequentially and 6% year‑over‑year on price. Full‑year 2024 margins for the segment were 20%, compared with 23% in 2023, while the fourth‑quarter margin fell to 22% from 30% in 2023. The segment’s 2024 net‑sales decline of 2% was driven by a 6% price decline and a 4% volume increase, underscoring the pricing pressure the company faces.
Celanese’s decision to lift prices is a direct response to rising input costs and weak demand in the chemicals market. By raising the price of its core acetyl‑chain products, the company aims to protect its gross‑margin profile and preserve operating profitability. The move also reflects the company’s broader strategy of cost reduction and deleveraging, which has been a focus in recent quarters as Celanese seeks to strengthen its balance sheet and free‑cash‑flow generation.
Beyond Acetyl Chain, Celanese’s Engineered Materials segment reported net sales of $5.6 billion in 2024, a 9% decline year‑over‑year, highlighting the competitive pressure across the business. The price increases in the Acetyl Chain segment are therefore a targeted effort to offset margin compression in a segment that remains a key contributor to the company’s overall financial health.
The pricing adjustment signals Celanese’s confidence in its pricing power despite a challenging market environment. By aligning product prices with input‑cost inflation, the company seeks to stabilize margins and support future growth, while continuing to monitor demand trends and competitive dynamics in the Western Hemisphere.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.